Gabriel Rogers

9PUBLICATIONS
27CO-AUTHORS
Disease surveillancePharmacogenomicsCross-sectional analysisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 15, 2026
Proactive case-finding and risk-stratification in people at risk of chronic liver disease in Greater Manchester: a cost-effectiveness analysis.

|Jul 08, 2026
Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling Methods.

|Jun 29, 2026
A Method for Estimating Resource Use and Costs when Empirical Data Are Unavailable: Expert Elicitation Study Using the Example of Melanoma.

|Mar 16, 2026
Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Duc Binh Phan, Philip Laws, Catherine H Smith

|May 16, 2024
A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening.

Stuart J Wright, Ewan Gray, Gabriel Rogers

|Feb 29, 2024
The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.

Bruce Guthrie, Gabriel Rogers, Shona Livingstone

Pageof 2

Frequent Collaborators

4 joint publications

Robert Hainsworth

4 joint publications

Katherine Payne

3 joint publications

Bruce Guthrie

2 joint publications

Alexander Thompson